News
Among more than 5,000 reproductive age women, 66.4% had one or more known modifiable risk factors, with this percentage ...
New gene therapies that can come with a one-time cost of more than $2 million also are having an impact, insurance brokers ...
"The Mediterranean diet, rich in fiber, whole grains, antioxidants, and anti-inflammatory compounds, is known to reduce ...
Regular blood testing to check for toxicity from standard rheumatoid arthritis drugs is recommended. Results of this ...
Moderate-to-severe traumatic brain injury (TBI) increased malignant brain tumor risk in a large retrospective study of ...
The Alliance for Natural Health joined Xlear in a separate petition in May demanding that the FTC drop its requirement for ...
A recent analysis of industry payment data showed that more than $12 billion in payments were made to physicians from 2013 to ...
Across 99 studies examining the effects of high-concentration THC products on mental health outcomes, 70% of the ...
HHS has moved to strip thousands of federal health agency employees of their collective bargaining rights, according to a ...
The PCSK9 inhibitor evolocumab (Repatha) got the FDA's blessing for cardiovascular protection, with or without a history of cardiovascular disease (CVD).
I used to ignore AI-generated suggested responses to patients, but they seem to be improving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results